Duality Advisers, LP Acadia Pharmaceuticals Inc Transaction History

Duality Advisers, LP

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Jun 27, 2023	BUY	$16.32 - $20.92 $101,445 - $130,038	6,216 Added 7.34%	90,881 $1.71 Million
Q4 2022 Feb 07, 2023	SELL	$14.2 - $18.63 $391,550 - $513,703	-27,574 Reduced 24.57%	84,665 $1.35 Million
Q3 2022 Nov 03, 2022	SELL	$14.11 - $18.27 $1.42 Million - $1.84 Million	-100,855 Reduced 47.33%	112,239 $1.84 Million
Q2 2022 Aug 08, 2022	BUY	$13.01 - $27.22 $2.48 Million - $5.2 Million	190,976 Added 863.44%	213,094 $3 Million
Q1 2022 May 09, 2022	BUY	$20.94 - $27.5 $463,150 - $608,245	22,118 New	22,118 $536,000
Q4 2021 Feb 02, 2022	SELL	$16.79 - $27.09 $2.22 Million - $3.58 Million	-132,205 Closed	0 $0
Q3 2021 Nov 08, 2021	BUY	$15.78 - $24.77 $1.92 Million - $3.01 Million	121,596 Added 1146.16%	132,205 $2.2 Million
Q2 2021 Aug 09, 2021	SELL	$19.4 - $27.42 $111,200 - $157,171	-5,732 Reduced 35.08%	10,609 $259,000
Q1 2021 May 13, 2021	SELL	$25.02 - $54.99 $307,670 - $676,212	-12,297 Reduced 42.94%	16,341 $422,000
Q4 2020 Feb 09, 2021	BUY	$41.04 - $56.79 $1.18 Million - $1.63 Million	28,638 New	28,638 $1.53 Million

279

156M

901K

314K

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.76B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

Get notified when there are updates to the investment portfolio of Duality Advisers, LP, based on Form 13F filings with the SEC.

Stay updated on Duality Advisers, LP with notifications on news.